The role of glycan modifications in health and disease

This publication has 118 references indexed in Scilit:

• Sulfated Glycosaminoglycans as Inhibitors for Chlamydia Infections: Molecular Weight and Sulfation Dependence
  Macromolecular Bioscience, 2025
• Inhibition of sulfated glycans on the binding of dengue virus envelope protein to heparin
  Glycoconjugate Journal, 2024
• The extracellular heparan sulfatase SULF2 limits myeloid IFNβ signaling and Th17 responses in inflammatory arthritis
  Cellular and Molecular Life Sciences, 2024
• Sulfated motifs in heparan sulfate inhibit Streptococcus pneumoniae adhesion onto fibronectin and attenuate corneal infection
  Proteoglycan Research, 2023
• Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2–Platelet‐Derived Growth Factor Receptor Beta–Yes‐Associated Protein Signaling Axis
  Hepatology, 2021
• Minimum structural requirements for BMP-2-binding of heparin oligosaccharides
  Biomaterials, 2018
• The crystal structure of the estA protein, a virulence factor from Streptococcus pneumoniae
  Proteins: Structure, Function, and Bioinformatics, 2007
• 9‐O‐acetyl GD3 protects tumor cells from apoptosis
  International Journal of Cancer, 2006
• Class Assignment of Sequence‐Unrelated Members of Enzyme Superfamilies by Activity‐Based Protein Profiling
  Angewandte Chemie International Edition, 2005
• The receptor‐destroying enzyme of influenza C virus is neuraminate‐O‐acetylesterase.
  The EMBO Journal, 1985